HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alefacept treatment of psoriatic nail disease: how severe should nail psoriasis be?

AuthorsJohn E M Körver, Peter C M van de Kerkhof, Marcel C Pasch
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 54 Issue 4 Pg. 742-3 (Apr 2006) ISSN: 1097-6787 [Electronic] United States
PMID16546613 (Publication Type: Comment, Letter)
Chemical References
  • Recombinant Fusion Proteins
  • alefacept
Topics
  • Humans
  • Nail Diseases (drug therapy)
  • Psoriasis (drug therapy)
  • Recombinant Fusion Proteins (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD